Dr. Mulki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Mount Auburn St
Ste 513
Cambridge, MA 02138Phone+1 617-576-1102
Education & Training
St Elizabeth's Medical CenterResidency, Internal Medicine, 2016
Damascus University Faculty of MedicineClass of 2006
Certifications & Licensure
MA State Medical License 2009 - 2025
RI State Medical License 2013 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 104 citationsThe CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections.Eri Katsuyama, Abel Suárez-Fueyo, Sean J. Bradley, Masayuki Mizui, Ana V. Marin
Cell Reports. 2020-01-07 - 32 citationsCytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularizationEiichi Hasegawa, Saori Inafuku, Lama Mulki, Yoko Okunuki, Ryoji Yanai
Proceedings of the National Academy of Sciences of the United States of America. 2017-09-05 - 65 citationsCytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization.Ryoji Yanai, Lama Mulki, Eiichi Hasegawa, Kimio Takeuchi, Harry Sweigard
Proceedings of the National Academy of Sciences of the United States of America. 2014-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
